⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MBX News
MBX Biosciences, Inc. Common Stock
Form 8-K
sec.gov
MBX
MBX Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Highlights
globenewswire.com
MBX
MBX Biosciences Appoints Karen Basbaum as Chief Business Officer
globenewswire.com
MBX
CORRECTING & REPLACING -- MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
globenewswire.com
MBX
Form 8-K
sec.gov
MBX
MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
globenewswire.com
MBX
Form 8-K
sec.gov
MBX
MBX Biosciences to Participate in Upcoming March Investor Conferences
globenewswire.com
MBX
MBX Biosciences to Participate in Upcoming Investor Conferences
globenewswire.com
MBX
MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair
globenewswire.com
MBX